IJCRR - 14(12), June, 2022
Pages: 70-73
Association between Dyslipidemia and Diabetic Nephropathy in Type 2 Diabetic Patients: A Cross-Sectional Study
Author: Hanozia Hassan, Narindar Kumar, Muhammad Ibrahim Mengal, Aneel Kapoor, M Saqib Ur Rehman, Aamir Hussain
Category: Healthcare
[Download PDF]
Abstract:
Introduction: Type 2 diabetes is a severe disease. It contains hormones that produce certain metabolic abnormalities and long-term problems. Urine contains low but abnormal levels of albumin which is the initial stage called “microalbuminuria”. Aim: To examine the association between dyslipidemia and diabetic nephropathy in type 2 diabetic patients. Methodology: Overall, 110 type 2 diabetic patients were involved in this study. Their detailed clinical history was evaluated along with clinical examination, urine albumin creatinine ratio, serum lipid profile. Data was analyzed using the Chi-square test and ANOVA test. It was done by the software EPICAL. A p-value less than 0.05 was considered significant.Study design: A cross-sectional study. Place and duration: This study was conducted at Bilawal Medical College for Boys at LUMHS Jamshoro Pakistan from June 2020 to June 2021. Results: A total of45 patients were having normoalbuminuria, 25 were having overt proteinuria, and the rest 40 patients had microalbuminuria. The most significant lipid abnormalities found in this study was increased LDL and increased triglyceride. Patients having Normoalbuminuria and overt proteinuria were compared and it was found that LDL and triglyceride had a positive correlation. As triglycerides increased, LDL also increased. Both had a p-value <0.001. Conclusion: Lipid abnormalities associated with diabetic nephropathy were increased low-density lipoprotein (LDL) and triglyceride.
Keywords: Diabetic nephropathy, Dyslipidemia, Low density lipoprotein, Triglycerides, Metabolic abnormalities, Proteinuria
Citation:
Hanozia Hassan, Narindar Kumar, Muhammad Ibrahim Mengal, Aneel Kapoor, M Saqib Ur Rehman, Aamir Hussain. Association between Dyslipidemia and Diabetic Nephropathy in Type 2 Diabetic Patients: A Cross-Sectional Study International Journal of Current Research and Review. 14(12), June, 70-73
References:
1. Takemura T, Yoshioka K, Aya N, Murakami K, Matumoto A, Itakura H, Kodama T, Suzuki H, Maki S. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney international. 1993 Apr 1; 43(4):918-27.
2. Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am. J. Kidney Dis. 1993 Jul 1; 22(1):72-82.
3. Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am. J. Kidney Dis. 1993 Jul 1; 22(1):72-82.
4. Jisieike-Onuigbo NN, Unuigbe EI, Kalu OA, Oguejiofor CO, Onuigbo PC. Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra state South-East Nigeria. Niger. J. Clin. Pract.. 2011; 14(2):171-5.
5. Jisieike NN. The prevalence of dyslipidemia and obesity among adult diabetic patients with overt nephropathy in south-eastern nigeria. Faculty of Pathology. 2008.
6. Berfield AK, Chait A, Oram JF, Zager RA, Johnson AC, Abrass CK. IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride. Am. J. Physiol. Renal Physiol. 2006; 290(1):F138- 47.
7. Gomez-Guerrero C, Hernandez-Vargas P, Lopez-Franco O, Ortiz-Munoz G, Egido J. Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches. Current Drug Targets-Inflammation & Allergy. 2005; 4(3):341- 51.
8. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur. J. Clin. 2004 Dec; 34(12):785-96.
9. Raptis AE, Viberti G. Pathogenesis of diabetic nephropathy. Experimental and Clinical Endocrinology & Diabetes. 2001; 109(Suppl 2):S424-37.
10. Song CY, Kim BC, Hong HK, Lee HS. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-β signaling in mesangial cells. Kidney international. 2005 May 1; 67(5):1743-52.
11. Nagase M, Kaname S, Nagase T, Wang G, Ando K, Sawamura T, Fujita T. Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J. Am. Soc. Nephrol. 2000 Oct 1; 11(10):1826-36.
12. Alice LY, Lorenz RL, Haritoglou C, Kampik A, Welge-Lussen U. Biological effects of native and oxidized low-density lipoproteins in cultured human retinal pigment epithelial cells. Experimental eye research. 2009 Mar 1; 88(3):495-503.
13. Krishnan SM, Kraehling JR, Eitner F, Bénardeau A, Sandner P. The impact of the nitric oxide (NO)/soluble guanylyl cyclase (sGC) signaling cascade on kidney health and disease: a preclinical perspective. Int. J. Mol. Sci. 2018 Jun; 19(6):1712.
14. Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, Malle E, Olbricht CJ, Walli AK, Gröne HJ. Oxidant stress in hyperlipidemia-induced renal damage. Am. J. Physiol. Renal Physiol. 2000.
15. Tonolo G, Cherchi S. Tubulointerstitial disease in diabetic nephropathy. Int J Nephrol Renovasc Dis 2014; 7:107.
16. Marateb HR, Mansourian M, Faghihimani E, Amini M, Farina D. A hybrid intelligent system for diagnosing microalbuminuria in type 2 diabetes patients without having to measure urinary albumin. Computers in biology and medicine. 2014 Feb 1; 45:34- 42.
17. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. Results of the national cholesterol education (NCEP) program evaluation project utilizing novel E-technology (NEPTUNE) II survey and implications for treatment under the recent NCEP writing group recommendations. Am J Cardiol. 2005 Aug 15; 96(4):556-63.
18. Afghahi H, Cederholm J, Eliasson B, Zethelius B, Gudbjörnsdottir S, Hadimeri H, Svensson MK. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes— the Swedish National Diabetes Register (NDR). Nephrology Dialysis Transplantation. 2011 Apr 1; 26(4):1236-43.
19. Cases A, Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney international. 2005 Dec 1; 68:S87-93.
20. Zhang F, Guan W, Fu Z, Zhou L, Guo W, Ma Y, Gong Y, Jiang W, Liang H, Zhou H. Relationship between serum indirect bilirubin level and insulin sensitivity: Results from two independent cohorts of obese patients with impaired glucose regulation and type 2 diabetes mellitus in China. Int. J. Endocrinol. 2020 Jul 29; 2020
|